[49F4-49F4];[50A13-50A13];
A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
49F4;50A13
Breakpoint based on release 3 sequence coordinate from Thibault et al., 2004, Supplementary Table 2 (FBrf0174227) or 3 (FBrf0174228), converted to release 5 coordinate.
Breakpoint from FlyBase's release 5 sequence location of progenitor insertion.
Df(2R)BSC273 heterozygotes show an apparently normal temperature preference profile and an apparently normal circadian behavior (i.e. proportion of rhythmicity and circadian period), as compared to wild-type controls.
Dominantly modifies the size of pupae relative to wild-type controls.
The presence of P+PBac{XP5.RB3}BSC273 was verified using the PCR methods and primers described in FBrf0175003.
Exelixis, Inc. determined the insertion site of P{XP}d07887 to be at Release 3 genomic coordinate 8566864 on chromosome arm 2R. This corresponds to 50A13 on the Release 3 and 4 genome maps. The predicted position of PBac{RB}Cap-Ge00771 on the Release 4 map is 49F4. Consequently, the cytological breakpoints of Df(2R)BSC273 are predicted to be 49F4;50A13.